Customceutical Compounding has voluntarily recalled 101 units of various compounded sterile injectable medications, including BPlex, Glutathione, HCG, Lipoplex, Testosterone (Test D and Test PROCYP), and Trimix. These products are being recalled because there is a lack of assurance that the medications are sterile, which can lead to serious infections. These medications were distributed nationwide to patients and clinics in various vial sizes ranging from 2 mL to 12 mL. Patients who have these injectable products should contact their healthcare provider or pharmacist for guidance and stop using the medication immediately.
If an injectable drug intended to be sterile is contaminated, it can cause life-threatening infections or localized reactions at the site of injection. No specific injuries or infections have been reported to date, but the failure to guarantee sterility poses a significant health risk to patients.
Contact healthcare provider and return product.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.